Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Tolterodine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tolterodine 2mg tablets
0704020N0AAABAB
|
Tolterodine | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | 107,736 |
|
Neditol XL 4mg capsules
0704020N0BFAAAC
|
Neditol XL | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | 52,508 |
|
Tolterodine 1mg tablets
0704020N0AAAAAA
|
Tolterodine | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | 45,305 |
|
Tolterodine 4mg modified-release capsules
0704020N0AAACAC
|
Tolterodine | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | 40,921 |
|
Tolterodine 2mg modified-release capsules
0704020N0AAAIAI
|
Tolterodine | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | 9,241 |
|
Tolthen XL 4mg capsules
0704020N0BJABAC
|
Tolthen XL | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | 7,396 |
|
Mariosea XL 4mg capsules
0704020N0BDAAAC
|
Mariosea XL | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | 6,624 |
|
Neditol XL 2mg capsules
0704020N0BFABAI
|
Neditol XL | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | 5,336 |
|
Detrusitol XL 4mg capsules
0704020N0BBACAC
|
Detrusitol | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | 2,395 |
|
Blerone XL 4mg capsules
0704020N0BHAAAC
|
Blerone XL | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1,987 |
|
Detrusitol 2mg tablets
0704020N0BBABAB
|
Detrusitol | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1,061 |
|
Tolthen XL 2mg capsules
0704020N0BJAAAI
|
Tolthen XL | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1,006 |
|
Mariosea XL 2mg capsules
0704020N0BDABAI
|
Mariosea XL | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | 267 |
|
Detrusitol 1mg tablets
0704020N0BBAAAA
|
Detrusitol | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | 263 |
|
Tolterodine 2mg/5ml oral suspension
0704020N0AAAJAJ
|
Tolterodine | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | 182 |
|
Preblacon XL 4mg capsules
0704020N0BGAAAC
|
Preblacon XL | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | 85 |
|
Tolterma XL 4mg capsules
0704020N0BKAAAC
|
Tolterma XL | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | 41 |
|
Tolterma XL 2mg capsules
0704020N0BKABAI
|
Tolterma XL | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | 7 |
|
Efflosomyl XL 4mg capsules
0704020N0BEAAAC
|
Efflosomyl XL | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | 2 |
|
Inconex XL 4mg capsules
0704020N0BIAAAC
|
Inconex XL | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Santizor XL 4mg capsules
0704020N0BCAAAC
|
Santizor XL | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Tolterodine 1mg/5ml oral liquid
0704020N0AAAHAH
|
Tolterodine | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Tolterodine 2mg oral powder sachets
0704020N0AAAFAF
|
Tolterodine | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Tolterodine 2mg/5ml oral solution
0704020N0AAAEAE
|
Tolterodine | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Tolterodine 4mg/5ml oral liquid
0704020N0AAAGAG
|
Tolterodine | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.